CD40LG and malaria: Parasite‐specific IgM+ MBCs have been detected in P. falciparum‐exposed individuals (Krishnamurty et al, 2016) and IgM antibodies specific for blood‐stage antigens have been found to be associated with protection from symptomatic malaria (Arama et al, 2015; Boyle et al, 2019).